162 related articles for article (PubMed ID: 36450989)
21. Resting-State fMRI-Based Screening of Deschloroclozapine in Rhesus Macaques Predicts Dosage-Dependent Behavioral Effects.
Fujimoto A; Elorette C; Fredericks JM; Fujimoto SH; Fleysher L; Rudebeck PH; Russ BE
J Neurosci; 2022 Jul; 42(29):5705-5716. PubMed ID: 35701162
[TBL] [Abstract][Full Text] [Related]
22. Chemogenetic stimulation of the G
Kim JH; Rahman MH; Lee WH; Suk K
Pharmacol Res Perspect; 2021 Dec; 9(6):e00822. PubMed ID: 34676988
[TBL] [Abstract][Full Text] [Related]
23. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model.
Desloovere J; Boon P; Larsen LE; Goossens MG; Delbeke J; Carrette E; Wadman W; Vonck K; Raedt R
Neurotherapeutics; 2022 Jan; 19(1):342-351. PubMed ID: 34862591
[TBL] [Abstract][Full Text] [Related]
24. Chemogenetic enhancement of functional recovery after a sciatic nerve injury.
Jaiswal PB; English AW
Eur J Neurosci; 2017 May; 45(10):1252-1257. PubMed ID: 28244163
[TBL] [Abstract][Full Text] [Related]
25. Repeated chemogenetic activation of dopaminergic neurons induces reversible changes in baseline and amphetamine-induced behaviors.
Chohan MO; Fein H; Mirro S; O'Reilly KC; Veenstra-VanderWeele J
Psychopharmacology (Berl); 2023 Dec; 240(12):2545-2560. PubMed ID: 37594501
[TBL] [Abstract][Full Text] [Related]
26. Chemogenetic Manipulation of Amygdala Kappa Opioid Receptor Neurons Modulates Amygdala Neuronal Activity and Neuropathic Pain Behaviors.
Ji G; Presto P; Kiritoshi T; Chen Y; Navratilova E; Porreca F; Neugebauer V
Cells; 2024 Apr; 13(8):. PubMed ID: 38667320
[TBL] [Abstract][Full Text] [Related]
27. Chronic hM4Di-DREADD-Mediated Chemogenetic Inhibition of Forebrain Excitatory Neurons in Postnatal or Juvenile Life Does Not Alter Adult Mood-Related Behavior.
Tiwari P; Kapri D; Pradhan A; Balakrishnan A; Chaudhari PR; Vaidya VA
eNeuro; 2022; 9(1):. PubMed ID: 35115382
[TBL] [Abstract][Full Text] [Related]
28. Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.
Wang YC; Galeffi F; Wang W; Li X; Lu L; Sheng H; Hoffmann U; Turner DA; Yang W
Exp Neurol; 2020 Apr; 326():113206. PubMed ID: 31962128
[TBL] [Abstract][Full Text] [Related]
29. Chemogenetic activation of nigrostriatal dopamine neurons in freely moving common marmosets.
Mimura K; Nagai Y; Inoue KI; Matsumoto J; Hori Y; Sato C; Kimura K; Okauchi T; Hirabayashi T; Nishijo H; Yahata N; Takada M; Suhara T; Higuchi M; Minamimoto T
iScience; 2021 Sep; 24(9):103066. PubMed ID: 34568790
[TBL] [Abstract][Full Text] [Related]
30. Chemogenetic Activation of CX3CR1-Expressing Spinal Microglia Using Gq-DREADD Elicits Mechanical Allodynia in Male Mice.
Saika F; Matsuzaki S; Kishioka S; Kiguchi N
Cells; 2021 Apr; 10(4):. PubMed ID: 33921365
[TBL] [Abstract][Full Text] [Related]
31. Gram scale preparation of clozapine
van der Peet PL; Gunawan C; Abdul-Ridha A; Ma S; Scott DJ; Gundlach AL; Bathgate RAD; White JM; Williams SJ
MethodsX; 2018; 5():257-267. PubMed ID: 30038895
[TBL] [Abstract][Full Text] [Related]
32. Comparison of three DREADD agonists acting on Gq-DREADDs in the ventral tegmental area to alter locomotor activity in tyrosine hydroxylase:Cre male and female rats.
Robinson HL; Nicholson KL; Shelton KL; Hamilton PJ; Banks ML
Behav Brain Res; 2023 Oct; 455():114674. PubMed ID: 37722510
[TBL] [Abstract][Full Text] [Related]
33. G
Marciante AB; Farmer GE; Cunningham JT
J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
[TBL] [Abstract][Full Text] [Related]
34. Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
Ji B; Kaneko H; Minamimoto T; Inoue H; Takeuchi H; Kumata K; Zhang MR; Aoki I; Seki C; Ono M; Tokunaga M; Tsukamoto S; Tanabe K; Shin RM; Minamihisamatsu T; Kito S; Richmond BJ; Suhara T; Higuchi M
J Neurosci; 2016 Nov; 36(45):11544-11558. PubMed ID: 27911758
[TBL] [Abstract][Full Text] [Related]
35. Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats.
Nentwig TB; Obray JD; Vaughan DT; Chandler LJ
Sci Rep; 2022 Apr; 12(1):6595. PubMed ID: 35449195
[TBL] [Abstract][Full Text] [Related]
36. A Feasibility Study to Investigate Chemogenetic Modulation of the Locus Coeruleus by Means of Single Unit Activity.
Stevens L; Vonck K; Larsen LE; Van Lysebettens W; Germonpré C; Baekelandt V; Van den Haute C; Carrette E; Wadman WJ; Boon P; Raedt R
Front Neurosci; 2020; 14():162. PubMed ID: 32210746
[TBL] [Abstract][Full Text] [Related]
37. DREADD-based synthetic control of chondrocyte calcium signaling in vitro.
McDonough RC; Shoga JS; Price C
J Orthop Res; 2019 Jul; 37(7):1518-1529. PubMed ID: 30908734
[TBL] [Abstract][Full Text] [Related]
38. Chronic Chemogenetic Stimulation of the Nucleus Accumbens Produces Lasting Reductions in Binge Drinking and Ameliorates Alcohol-Related Morphological and Transcriptional Changes.
Pozhidayeva DY; Farris SP; Goeke CM; Firsick EJ; Townsley KG; Guizzetti M; Ozburn AR
Brain Sci; 2020 Feb; 10(2):. PubMed ID: 32085427
[TBL] [Abstract][Full Text] [Related]
39. Chronic hM3Dq-DREADD-mediated chemogenetic activation of parvalbumin-positive inhibitory interneurons in postnatal life alters anxiety and despair-like behavior in adulthood in a task- and sex-dependent manner.
Banerjee T; Pati S; Tiwari P; Vaidya VA
J Biosci; 2022; 47():. PubMed ID: 36476774
[TBL] [Abstract][Full Text] [Related]
40. Testing Effects of Chronic Chemogenetic Neuronal Stimulation on Energy Balance by Indirect Calorimetry.
Yu S; Münzberg H
Bio Protoc; 2018 Apr; 8(8):. PubMed ID: 29951570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
